Security key
M74240108
NeuroSense Therapeutics Ltd. - ORDINARY SHARES (NRSN)
CUSIP: M74240108
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / ORDINARY SHARES
- Total 13F shares
- 779,367
- Total 13F value
- $554,109
- Share change
- -695,129
- SEC-reported price per share
- $0.71
- Number of holders
- 5
- Value change
- -$580,781
- Number of buys
- 2
- Number of sells
- 4
Report period
Q3 2023
Institutions
5
Top holders
5
NRSN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2023
Previous quarter: Q2 2023
NeuroSense Therapeutics Ltd. SEC filings
NeuroSense Therapeutics Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M74240108
Recent filing periods:
Ownership snapshot
Top reported holders of NRSN - NeuroSense Therapeutics Ltd. - ORDINARY SHARES (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/11
Latest evidence
30 Jun 2023
13F
Highest disclosed value: $1,886,340
11 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $1.89M.
0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$1.89M
Point72 Asset Management, L.P.
$149K
MEITAV INVESTMENT HOUSE LTD
$141.6K
Hudson Bay Capital Management LP
$20.7K
Vanguard Personalized Indexing Ma...
$16.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
class O/S missing
|
$1,886,340
1,266,000 shares
|
— | 30 Jun 2023 |
| Point72 Asset Management, L.P. |
13F
Company
|
—
class O/S missing
|
$149,000
100,000 shares
|
— | 30 Jun 2023 |
| MEITAV INVESTMENT HOUSE LTD |
13F
Company
|
—
class O/S missing
|
$141,550
95,000 shares
|
— | 30 Jun 2023 |
| Hudson Bay Capital Management LP |
13F
Company
|
—
class O/S missing
|
$20,732
87,734 shares
|
— | 30 Jun 2023 |
| Vanguard Personalized Indexing Management, LLC |
13F
Company
|
—
class O/S missing
|
$16,676
11,192 shares
|
— | 30 Jun 2023 |
| Warberg Asset Management LLC |
13F
Company
|
—
class O/S missing
|
$15,390
77,709 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
5
Shares
779,367
Rows available
5
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
6
Q3 2023 holders
5
Holder diff
-1
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend